More clients gain access to breakthrough cancer screening test
In late 2022, John Hancock offered a pilot group of customers access to the Galleri® test — a breakthrough multi-cancer early detection tool, named a best invention of 2022 by TIME. The response from the pilot was resounding: Customers want access to this type of technology and the deeper insights into their health the Galleri test can offer.
Today, we are excited to announce that all your eligible John Hancock Vitality PLUS clients now have access to the Galleri test, part of our commitment to helping customers live longer, healthier, better lives.
Here are the key things to know:
What is the Galleri test?
The Galleri test can screen for more than 50 types of cancer with a single blood draw and indicate where in the body a cancer signal may be coming from.
Who is eligible for access to the Galleri test?
To be eligible for access to the Galleri test through John Hancock Vitality PLUS, your clients must:
- Be registered Vitality PLUS members who are 50 years of age or older
- Have completed the Vitality Health Review (VHR) for the current program year
The above criteria apply to new and inforce term and permanent policies. John Hancock will reach out to eligible new customers after their policies are placed as part of the Vitality registration and onboarding process.
Is there a cost?
For eligible polices with coverage amounts of $500,000 or greater, 100% of the cost of the test will be subsidized ($950 value).
For eligible policies with less than $500,000 in coverage, 50% of the cost of the test will be subsidized (customer will pay $475).